Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Measurement Of Inflammatory Markers In The Breath Condensate Of Children With Cystic Fibrosis.

S. Cunningham, J. R. Mccolm, L. P. Ho, A. Greening, T. Marshall
Published 2000 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Identifying noninvasive markers of pulmonary inflammation would be useful in assessing new therapies in children. Breath condensate is a simple and potentially acceptable sample medium even in small children. The technique has previously been used in adults, but not children with cystic fibrosis. The technique was assessed in 36 children with cystic fibrosis (mean age 10.4 yrs) and 17 control subjects, analysing samples for nitrite, interleukin(IL)-8 and salivary and nasal contamination. Correlations were made between levels of the inflammatory markers and forced expiratory volume in one second/forced vital capacity, chest radiograph score and use of inhaled steroids. On samples without significant contamination (<10 u x L(-1) amylase) nitrite was detected in 93% of samples at a median concentration of 3.0 microM compared with 50% of control samples at a median of 0.5 microM. Condensate amylase levels did not correlate with the nitrite value obtained (r=0.31). IL-8 was detected in 33% of CF samples. Breath condensate is an acceptable method of sample collection in children. Nitrite was raised in breath condensate from patients with cystic fibrosis when compared with control subjects.
This paper references
10.1136/adc.75.4.319
Reduced upper airway nitric oxide in cystic fibrosis.
I. Balfour-Lynn (1996)
10.1002/(SICI)1096-9896(199803)184:3<323::AID-PATH2>3.0.CO;2-2
Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis
Q. H. Meng (1998)
10.1136/thx.53.8.680
Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide
L. P. Ho (1998)
10.1002/(SICI)1099-0496(199709)24:3<173::AID-PPUL2>3.0.CO;2-O
Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis
H. Grasemann (1997)
10.1016/0140-6736(91)93111-L
Cystic fibrosis, breath pentane, and lipid peroxidation
D. Bilton (1991)
10.1164/AJRCCM/148.3.778
Detection of nonvolatile macromolecules in breath. A possible diagnostic tool?
L. Scheideler (1993)
10.1164/AJRCCM/148.4_PT_1.955
Expired breath hydrogen peroxide is a marker of acute airway inflammation in pediatric patients with asthma.
A. W. Dohlman (1993)
10.1183/09031936.98.12020483
Hydrogen peroxide in exhaled air of healthy children: reference values.
Q. Jöbsis (1998)
10.1203/00006450-199308000-00010
Interleukin-8 Concentrations Are Elevated in Bronchoalveolar Lavage, Sputum, and Sera of Children with Cystic Fibrosis
T. Dean (1993)
10.1016/0003-2697(82)90118-X
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.
L. C. Green (1982)
10.1136/bmj.310.6994.1571
Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis
D. Armstrong (1995)
10.1177/000456329503200301
Amylase Measurement—Which Method?
A. Y. Foo (1995)
10.1183/09031936.97.10061235
Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients.
A. Antczak (1997)
10.1164/AJRCCM.159.2.15921
Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis.
H. Grasemann (1999)



This paper is referenced by
10.1016/S0165-6147(02)02020-5
Analysis of exhaled breath condensate for monitoring airway inflammation.
P. Montuschi (2002)
10.1038/micronano.2017.22
Toward point-of-care management of chronic respiratory conditions: Electrochemical sensing of nitrite content in exhaled breath condensate using reduced graphene oxide
A. Gholizadeh (2017)
10.3109/9780203022153-11
Analysis of Exhaled Breath Condensate
Umur Hatipolu (2004)
10.1002/PPUL.20344
Markers of airway inflammation in primary ciliary dyskinesia studied using exhaled breath condensate
Nadwa Zihlif (2006)
10.1016/S0761-8425(08)73800-2
Mesure de l’inflammation pulmonaire dans la mucoviscidose
M. Fayon (2008)
10.1586/17476348.2.3.381
Assessment and monitoring of cystic fibrosis lung disease in infants and young children
C. Ren (2008)
10.3233/JPB-2011-0028
Nitric oxide: A promising biomarker for respiratory disorders
Nidhi Anil (2016)
10.1111/j.1399-3038.2007.00693.x
Biomarkers in exhaled breath condensate indicate presence and severity of cystic fibrosis in children
Charlotte M. H. H. T. Robroeks (2008)
10.1097/01.CPM.0000087520.71346.1C
Exhaled Breath Condensate: The Past, Present, and Future
Jon L. Freels (2003)
10.1385/CRIAI:23:1:041
Monitoring inflammation in CF
S. Sagel (2002)
Važnost analize kondenzata izdahnutog zraka u plućnim bolestima
I. Maloča (2006)
10.1179/135100004225005219
Non-invasive biomarkers of oxidative stress: reproducibility and methodological issues
I. Rahman (2004)
10.3109/15412555.2010.496818
Current Perspectives of Oxidative Stress and its Measurement in Chronic Obstructive Pulmonary Disease
J. Lin (2010)
10.5099/AJ100400365
Pulmonary oxidative status in norma and pathologies on the basis of analysis of exhaled breath condensate
E. Anaev (2010)
10.1097/ALN.0b013e31820d84db
Exhaled breath condensate in mechanically ventilated brain-injured patients with no lung injury or sepsis.
I. Korovesi (2011)
10.14712/18059694.2018.17
Exhaled Breath Condensate: Pilot Study of the Method and Initial Experience in Healthy Subjects.
E. Peterova (2018)
10.1186/1743-8977-9-12
Effects of wood smoke particles from wood-burning stoves on the respiratory health of atopic humans
I. Riddervold (2011)
10.1136/thx.2004.030635
Origin of nitrite and nitrate in nasal and exhaled breath condensate and relation to nitric oxide formation
H. Marteus (2005)
The development of exhaled breath condensate: a noninvasive method of measuring airway inflammation
P.P.R. Rosias (2008)
Exhaled Breath Condensate in Disease Monitoring
Ildikó Horváth (2003)
10.1002/PPUL.20719
Longitudinal monitoring of pediatric cystic fibrosis lung disease using nitrite in exhaled breath condensate
F. Horak (2007)
10.1016/S1569-1993(03)00062-6
Elemental and ion composition of exhaled air condensate in cystic fibrosis.
M. Griese (2003)
10.1097/01.CPM.0000059379.82525.4A
Exhaled Breath Condensate in Disease Monitoring
Ildik Horv th (2003)
10.1038/nrd751
Indirect monitoring of lung inflammation
P. Montuschi (2002)
Importance du stress oxydant dans le diabète secondaire à la fibrose kystique
Thierry Ntimbane (2010)
10.1080/10715760310001623331
ReviewBiomarkers in Breath Condensate: A promising New Non-invasive Technique in Free Radical Research
I. Rahman (2003)
10.1183/09031936.02.00229202
Mechanisms and markers of airway inflammation in cystic fibrosis
V. Rose (2002)
Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.
T. Ntimbane (2009)
10.1515/CCLM.2007.326
Exhaled breath condensate: a new method for lung disease diagnosis
I. Čepelak (2007)
10.1002/ppul.21167
Effects of a short‐term rehabilitation program on airway inflammation in children with cystic fibrosis
A. Moeller (2010)
10.1016/j.chroma.2012.06.085
Capillary electrophoresis--a new tool for ionic analysis of exhaled breath condensate.
P. Kubáň (2012)
10.1159/000083536
Exhaled Breath Condensate and Other Markers in Exhaled Air
A. Möller (2005)
See more
Semantic Scholar Logo Some data provided by SemanticScholar